(Q63727340)

English

The effect of etanercept and infliximab on the production of tumour necrosis factor α, interferon-γ and GM-CSF in in vivo activated intestinal T lymphocyte cultures

article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12906870%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

The effect of etanercept and infliximab on the production of tumour necrosis factor alpha, interferon-gamma and GM-CSF in in vivo activated intestinal T lymphocyte cultures (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12906870%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

0 references

0 references

Jørgen Agnholt

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12906870%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Jens F. Dahlerup

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12906870%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

Keld Kaltoft

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12906870%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 August 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12906870%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12906870%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12906870%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12906870%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

76-85

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12906870%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

In situ activated intestinal T cells expanded in vitro--without addition of antigen--produce IFN-gamma and IL-10 and preserve their function during growth

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2803%2900201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

INFLIXIMAB DOWNREGULATES INTERFERON-γ PRODUCTION IN ACTIVATED GUT T-LYMPHOCYTES FROM PATIENTS WITH CROHN'S DISEASE

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2803%2900201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The 26-kD transmembrane form of tumor necrosis factor alpha on activated CD4+ T cell clones provides a costimulatory signal for human B cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2803%2900201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2803%2900201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2803%2900201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2803%2900201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Etanercept in the treatment of active refractory Crohn's disease: a single-center pilot trial

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2803%2900201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Triggered human mucosal T cells release tumour necrosis factor-alpha and interferon-gamma which kill human colonic epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2803%2900201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2803%2900201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Crohn's disease: not all anti-TNFs are the same!

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2803%2900201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Highly polarized HLA class II antigen processing and presentation by human intestinal epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2803%2900201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2803%2900201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Granulocyte-macrophage colony-stimulating factor (GM-CSF) has opposing effects on the capacity of monocytes versus monocyte-derived dendritic cells to stimulate the antigen-specific proliferation of a human T cell clone

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2803%2900201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased mucosal production of granulocyte colony-stimulating factor is related to a delay in neutrophil apoptosis in Inflammatory Bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2803%2900201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro genetically aberrant T-cell clones with continuous growth are associated with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2803%2900201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Breakdown of tolerance to the intestinal bacterial flora in inflammatory bowel disease (IBD)

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2803%2900201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Recent developments in the immunology of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2803%2900201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancing Lamina propria Th1 cell responses with interleukin 12 produces severe tissue injury

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2803%2900201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Response of human intestinal lamina propria T lymphocytes to interleukin 12: additive effects of interleukin 15 and 7

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2803%2900201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokine-induced impairment of short-chain fatty acid oxidation and viability in human colonic epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2803%2900201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Infliximab for the treatment of fistulas in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2803%2900201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced mucosal cytokine production in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2803%2900201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2803%2900201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2803%2900201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2803%2900201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2803%2900201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Protein transport and processing by human HT29-19A intestinal cells: effect of interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2803%2900201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunotherapy of Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2803%2900201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Transmembrane TNF-alpha, induction of apoptosis, and the efficacy of TNF-targeting therapies in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2803%2900201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

p38 mitogen-activated protein kinase is activated and linked to TNF-alpha signaling in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2803%2900201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1043-4666(03)00201-1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12906870%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12906870%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q63727340&oldid=1414242680"